| Literature DB >> 28389435 |
Jonathan Kaufman1,2,3, Patrick Fitzpatrick1,2, Shidan Tosif1,2,3, Sandy M Hopper1,2, Susan M Donath2,3, Penelope A Bryant1,2,3, Franz E Babl4,2,3.
Abstract
Objective To determine if a simple stimulation method increases the rate of infant voiding for clean catch urine within five minutes.Design Randomised controlled trial.Setting Emergency department of a tertiary paediatric hospital, Australia.Participants 354 infants (aged 1-12 months) requiring urine sample collection as determined by the treating clinician. 10 infants were subsequently excluded.Interventions Infants were randomised to either gentle suprapubic cutaneous stimulation (n=174) using gauze soaked in cold fluid (the Quick-Wee method) or standard clean catch urine with no additional stimulation (n=170), for five minutes.Main outcome measures The primary outcome was voiding of urine within five minutes. Secondary outcomes were successful collection of a urine sample, contamination rate, and parental and clinician satisfaction with the method.Results The Quick-Wee method resulted in a significantly higher rate of voiding within five minutes compared with standard clean catch urine (31% v 12%, P<0.001), difference in proportions 19% favouring Quick-Wee (95% confidence interval for difference 11% to 28%). Quick-Wee had a higher rate of successful urine sample collection (30% v 9%, P<0.001) and greater parental and clinician satisfaction (median 2 v 3 on a 5 point Likert scale, P<0.001). The difference in contamination between Quick-Wee and standard clean catch urine was not significant (27% v 45%, P=0.29). The number needed to treat was 4.7 (95% confidence interval 3.4 to 7.7) to successfully collect one additional urine sample within five minutes using Quick-Wee compared with standard clean catch urine.Conclusions Quick-Wee is a simple cutaneous stimulation method that significantly increases the five minute voiding and success rate of clean catch urine collection.Trial registration Australian New Zealand Clinical Trials Registry ACTRN12615000754549. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.Entities:
Mesh:
Year: 2017 PMID: 28389435 PMCID: PMC6284210 DOI: 10.1136/bmj.j1341
Source DB: PubMed Journal: BMJ ISSN: 0959-8138

Fig 1 Quick-Wee voiding stimulation method of gentle cutaneous suprapubic stimulation using gauze soaked in cold fluid. Image courtesy of Bill Reid, Royal Children’s Hospital creative studio

Fig 2 Flow of participants through study
Demographic and clinical characteristics of participants. Values are number (percentage) of participants unless stated otherwise
| Characteristics | Quick-Wee (n=174) | Standard clean catch urine (n=170) |
|---|---|---|
| Male | 95 (55) | 77 (45) |
| Mean (SD) age in months | 5.4 (3.2) | 5.4 (3.0) |
| Previous UTI | 10 (6) | 15 (9) |
| Antibiotics in past 24 hours | 9 (5) | 10 (6) |
| Comorbidities: | ||
| Minor renal anomaly | 8 (5) | 7 (4) |
| Congenital cardiac | 3 (2) | 1 (0.6) |
| Seizure disorder | 3 (2) | 0 (0) |
| Genetic syndrome | 0 (0) | 2 (1) |
| Gastro-oesophageal reflux | 2 (1) | 2 (1) |
| Other | 3 (2) | 2 (1) |
| Indication for urine sample*: | ||
| Fever of unknown origin | 78 (45) | 66 (39) |
| Unsettled baby | 66 (38) | 66 (39) |
| Poor feeding | 33 (19) | 43 (25) |
| Specifically suspected UTI | 29 (17) | 27 (16) |
| Vomiting | 17 (10) | 10 (6) |
| Failure to thrive | 1 (1) | 7 (4) |
| Metabolic/electrolyte/jaundice | 0 (0) | 3 (2) |
| Haematuria | 2 (1) | 1 (1) |
| Other | 6 (3) | 6 (4) |
| Hydration state: | ||
| Normal | 120 (69) | 132 (78) |
| Mild | 48 (28) | 33 (19) |
| Moderate | 5 (3) | 2 (1) |
| Severe | 0 (0) | 1 (1) |
UTI=urinary tract infection.
Apparent discrepancies are due to rounding.
*More than one indication may be selected.
Primary and secondary outcomes
| Outcomes | Quick-Wee (n=174) | % (95% CI) | Standard clean catch urine (n=170) | % (95% CI) | Difference in proportions or medians (95% CI) | P value |
|---|---|---|---|---|---|---|
| Primary outcome: | ||||||
| Voided <5 mins | 54/174 | 31 (24 to 39) | 20/170 | 12 (7 to 18) | 19 (11 to 28) | <0.001* |
| Secondary outcomes: | ||||||
| Voided and successful catch | 52/174 | 30 (23 to 37) | 15/170 | 9 (5 to 14) | 21 (13 to 29) | <0.001* |
| Contamination† | 12/44 | 27 (15 to 43) | 5/11 | 46 (17 to 77) | 18 (−14 to 50) | 0.29‡ |
| Median (interquartile range) parent satisfaction§ | 2 (1-3) | 3 (2-3) | 1 (0.6 to 1.4) | <0.001¶ | ||
| Median (interquartile range) clinician satisfaction§ | 2 (1-3) | 3 (2-3) | 1 (0.6 to 1.4) | <0.001¶ |
*χ2 test.
†Small proportion of samples in each group not sent for culture by treating clinician.
‡Fisher’s exact test.
§5 point Likert scale: 1=very satisfied, 2=satisfied, 3=neutral, 4=unsatisfied, 5=very unsatisfied.
¶Wilcoxon rank sum test.